Is the 6MWT still the best endpoint for Pompe disease clinic

The 6-minute walk test has long been the consensus primary measure for Pompe disease drug studies, but some experts are calling for change.

Related Keywords

Italy , Barry Byrne , Sanofi Nexviazyme , Carlos Javier Alm , Corrado Angelini , Gerald Cox , Genzyme Myozyme , Powell Gene Therapy Center , Contract Manufacturing Organisation , Contract Research Organisation For Clinical Trials , University Of Florida , Neuromuscular Center , University Of Padua , Forced Vital Capacity , Astellas Gene Therapies , Spark Therapeutics , Clinical Trials Arena , Manufacturing Organisation , Pharmaceutical Supply , Event Conception , Research Organisation ,